Ouabagenin L-Rhamnoside en es it fr

Ouabagenin L-Rhamnoside Brand names, Ouabagenin L-Rhamnoside Analogs

Ouabagenin L-Rhamnoside Brand Names Mixture

  • No information avaliable

Ouabagenin L-Rhamnoside Chemical_Formula

C29H44O12

Ouabagenin L-Rhamnoside RX_link

No information avaliable

Ouabagenin L-Rhamnoside fda sheet

Ouabagenin L-Rhamnoside msds (material safety sheet)

Ouabagenin L-Rhamnoside Synthesis Reference

No information avaliable

Ouabagenin L-Rhamnoside Molecular Weight

584.652 g/mol

Ouabagenin L-Rhamnoside Melting Point

200 oC

Ouabagenin L-Rhamnoside H2O Solubility

1.03E+004 mg/L

Ouabagenin L-Rhamnoside State

Solid

Ouabagenin L-Rhamnoside LogP

-2.038

Ouabagenin L-Rhamnoside Dosage Forms

No information avaliable

Ouabagenin L-Rhamnoside Indication

For the treatment of atrial fibrillation and flutter and heart failure

Ouabagenin L-Rhamnoside Pharmacology

Ouabain, a cardiac glycoside similar to digitoxin, is used to treat congestive heart failure and supraventricular arrhythmias due to reentry mechanisms, and to control ventricular rate in the treatment of chronic atrial fibrillation.

Ouabagenin L-Rhamnoside Absorption

No information avaliable

Ouabagenin L-Rhamnoside side effects and Toxicity

No information avaliable

Ouabagenin L-Rhamnoside Patient Information

No information avaliable

Ouabagenin L-Rhamnoside Organisms Affected

Humans and other mammals